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CANCER DIAGNOSIS USING LIBS AND MACHINE LEARNING TOOLS: PROGRESS 
AND CHALLENGES 
 
Noureddine Melikechi, PhD1, Rosalba Gaudiuso, PhD1,2, Ebo Ewusi-Annan, PhD1 
1Department of Physics and Applied Physics, University of Massachusetts Lowell; 2Institute 
of Nanotechnology Nanotec-CNR, Italy 
 
Despite numerous research and development efforts that provide important tools to fight 
cancer, this disease still poses great challenges to diagnosis and treatment, and it remains 
one of the leading causes of death worldwide. Early diagnosis is crucial to increase the 
survival rate and quality of life of cancer patients. Thus, developing non-invasive screening 
methods would represent a key step towards point-of-care large scale screening and 
prevention of asymptomatic tumors such as Epithelian Ovarian Cancer (EOC) and others. 
Our group has developed two experimental strategies to pursue early cancer diagnosis 
through Laser-Induced Breakdown Spectroscopy (LIBS), a versatile atomic spectroscopy 
technique whose main advantages are: little or no sample preparation required; real-time 
multi-elemental response; virtually no limitation about the kind of sample that can be 
analyzed. The first is a LIBS-based immunoassay (Tag-LIBS), where a cancer biomarker is 
tagged with a suitably functionalized inorganic microparticles, which are in turn quantitatively 
and sensitively detected by LIBS. The second is based on the direct analysis of biological 
fluids through the combined use of LIBS and machine learning algorithms. By combining 
femtosecond LIBS with unsupervised classification techniques, we have shown that it is 
possible to discriminate blood samples extracted from healthy and diseased mice with an 
accuracy that approaches 80%. We will present our most recent results obtained with both 
approaches, and in particular we will report about the effects of various substrates used for 
LIBS measurements on the classification accuracy of blood samples extracted from 
cancerous and healthy mice. 
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